Alphadyne Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Alphadyne Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,982	Closed	-$192K	–	867
2025 Q3	$180K	Buy	+3,982	New	+$186K	0.01%	274
2024 Q1	–	Sell	-12,921	Closed	-$663K	–	26
2023 Q4	$663K	Buy	12,921 +3,133	+32%	+$164K	0.24%	22
2023 Q3	$568K	Buy	9,788 +5,100	+109%	+$312K	0.04%	164
2023 Q2	$300K	Buy	+4,688	New	+$314K	0.04%	101

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Alphadyne Asset Management's BMY Position: Q4 2025 in Review

Alphadyne Asset Management sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 3,982 shares — an estimated $192K sold.

Alphadyne Asset Management first reported a position in BMY in Q2 2023 and held it in 4 quarters. The position peaked at $663K in Q4 2023. 2,447 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

Alphadyne Asset Management reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
Alphadyne Asset Management sold 3,982 Bristol-Myers Squibb shares in Q4 2025, an estimated $192K.
Alphadyne Asset Management first reported a position in Bristol-Myers Squibb in Q2 2023 and held it in 4 quarters.
Alphadyne Asset Management's Bristol-Myers Squibb position peaked at $663K in Q4 2023.
2,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Alphadyne Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.